Publications and communications of Clio RIBBENS

Dasnoy-Sumell, G., CHAPELLE, A.-C., Hansen, I., Lambert, N., Sprynger, M., Moonen, M., Rasquain, L., Poulet, C., Ribbens, C., Regnier, C., Von Frenckell, C., & Malaise, O. (December 2025). « Fast-track clinic » de l’artérite à cellules géantes : étude des capacités diagnostiques et des éléments influençant la décision d’instaurer une corticothérapie. Revue du Rhumatisme, 92, 119-A120. doi:10.1016/j.rhum.2025.10.442

Rinkin, C., Malaise, O., Lamaye, C., CHAUVEHEID, F., GERARD, C., Seidel, L., Malaise, M., Hustinx, R., & Ribbens, C. (October 2025). 18F-FDG PET/CT discriminates whether rheumatoid arthritis patients are in ultrasound remission or not. Rheumatology Advances in Practice, 9 (4), 125. doi:10.1093/rap/rkaf125

Massenet, T., Zanella, D., Potjewijd, J., Tobal, R., GESTER, F., Henket, M., Njock, M.-S., Dejong, T., Gridelet, G., GILTAY, L., GUISSARD, F., André, B., Ribbens, C., Louis, R., Van Paassen, P., Focant, J.-F., Guiot, J.* , & Stefanuto, P.-H.*. (15 September 2025). Towards Clinical Implementation: A multicentric study for the diagnosis and stratification of systemic sclerosis using TD-GC×GC-HRTOFMS [Poster presentation]. IABR Breath Summit 2025, Innsbruck, Austria.
* These authors have contributed equally to this work.

Malaise, O., Rinkin, C., GERARD, C., CHAUVEHEID, F., Seidel, L., Malaise, M., & Ribbens, C. (28 June 2025). Ultrasound- and clinical-defined disease activities are associated with altered bone microarchitecture and lower bone mineral density in patients with rheumatoid arthritis. Aging Clinical and Experimental Research, 37 (1), 199. doi:10.1007/s40520-025-03105-5

Paulissen, G., Malaise, O., Deroyer, C., Charlier, E., Neuville, S., Plener, Z., Thirion, T., Daniel, C., Ribbens, C., & de Seny, D. (2025). JAK inhibitors alleviate metabolic dysregulation, inflammation and fibrosis in osteoarthritis: insights from human joint cells and synovium. Rheumatology. doi:10.1093/rheumatology/keaf298

Bouquegneau, A., Ernst, M., Malaise, O., Seidel, L., Kaux, J.-F., Reginster, J.-Y., Cavalier, E., Ribbens, C., Jouret, F., Weekers, L., & Delanaye, P. (12 April 2025). Impact of corticosteroid withdrawal on bone mineral density after kidney transplantation. Aging Clinical and Experimental Research, 37 (1), 124. doi:10.1007/s40520-025-03018-3

Bouquegneau, A., Jouret, F., Seidel, L., BONVOISIN, C., Weekers, L., Ribbens, C., Bruyère, O., Cavalier, E., Delanaye, P., & Malaise, O. (07 March 2025). Trabecular bone score to assess bone microarchitecture in end-stage renal disease patients. Archives of Osteoporosis, 20 (1), 34. doi:10.1007/s11657-025-01519-2

Guiot, J., André, B., Potjewijd, J., JACQUERIE, P., Cremers, S., Henket, M., Idoufkir, L., Remacle, C., Tobal, R., GILTAY, L., Moermans, C., GESTER, F., Polese, B., Hamaïdia, M., Struman, I., Louis, E., Malaise, M., de Seny, D., van Paassen, P., ... Njock, M.-S. (2025). Association of fibrotic-related extracellular vesicle microRNAs with lung involvement in systemic sclerosis. European Respiratory Journal, 2400276. doi:10.1183/13993003.00276-2024

Guiot, J., Henket, M., GESTER, F., André, B., Ernst, B., Frix, A.-N., Smeets, D., Van Eyndhoven, S., Antoniou, K., Conemans, L., Gote-Schniering, J., Slabbynck, H., Kreuter, M., Sellares, J., Tomos, I., Yang, G., Ribbens, C., Louis, R., Cottin, V., ... Walsh, S. L. F. (24 January 2025). Automated AI-based image analysis for quantification and prediction of interstitial lung disease in systemic sclerosis patients. Respiratory Research, 26 (1), 39. doi:10.1186/s12931-025-03117-9

Massenet, T., Potjewijd, J., Tobal, R., GESTER, F., Zanella, D., Henket, M., Njock, M.-S., Dejong, T., Gridelet, G., GILTAY, L., GUISSARD, F., André, B., Ribbens, C., Louis, R., Van Paassen, P., Guiot, J., & Stefanuto, P.-H. (November 2024). Systemic Sclerosis: Can Breathomics help clinicians for ILD management? [Poster presentation]. Breath Biopsy Conference 2024.

Massenet, T., Patjewijd, J., Tobal, R., GESTER, F., Zanella, D., Henket, M., Njock, M.-S., Dejong, T., Gridelet, G., GILTAY, L., GUISSARD, F., André, B., Ribbens, C., Louis, R., Van Paassen, P., Guiot, J.* , & Stefanuto, P.-H.*. (08 September 2024). SYSTEMIC SCLEROSIS: CAN BREATHOMICS MONITOR INTERSTITIAL LUNG DISEASE? [Poster presentation]. The ERS Congress, Vienne, Austria.
* These authors have contributed equally to this work.

Bertrand, D., Joly, J., Neerinckx, B., Durez, P., Lenaerts, J., Joos, R., Thevissen, K., Zwaenepoel, T., Vanhoof, J., Di Romana, S., Taelman, V., Van Essche, E., Corluy, L., Ribbens, C., Berghe, M. V., Devinck, M., Ajeganova, S., Durnez, A., Boutsen, Y., ... The CareRA2020 Study group (Other coll.). (07 August 2024). Effectiveness of methotrexate and bridging glucocorticoids with or without early introduction of a 6-month course of etanercept in early RA: results of the 2-year, pragmatic, randomised CareRA2020 trial. RMD Open, 10 (3), 004535. doi:10.1136/rmdopen-2024-004535

Regnier, C., Mina, M., Chauveheid, F., Ribbens, C., & Malaise, O. (June 2024). Que faire pour prévenir l’ostéoporose ? Entre mythes et réalité scientifique. Revue Médicale de Liège, 79 (5-6), 429 - 435.

Massenet, T., Potjewijd, J., Tobal, R., GESTER, F., Zanella, D., Henket, M., Njock, M.-S., Dejong, T., Gridelet, G., GILTAY, L., GUISSARD, F., André, B., Ribbens, C., Louis, R., Van Paassen, P., Focant, J.-F., Guiot, J., & Stefanuto, P.-H. (28 May 2024). Tackling the analytical challenges to establish a routine workflow for breathomics research [Paper presentation]. 18th International Symposium on Hyphenated Techniques in Chromatography and Separation Technology (HTC-18), Leuven, Belgium.

Massenet, T., Potjewijd, J., Tobal, R., GESTER, F., Zanella, D., Henket, M., Njock, M.-S., Dejong, T., Gridelet, G., GILTAY, L., GUISSARD, F., André, B., Ribbens, C., Louis, R., Van Paassen, P., Guiot, J., & Stefanuto, P.-H. (2024). Breathomics to monitor interstitial lung disease associated with systemic sclerosis. ERJ Open Research, 00175-2024. doi:10.1183/23120541.00175-2024

Rinkin, C., Malaise, O., CHAUVEHEID, F., GERARD, C., Seidel, L., Malaise, M., & Ribbens, C. (07 May 2024). Optical imaging (HandScan) can identify ultrasound remission in rheumatoid arthritis. BMC Musculoskeletal Disorders, 25 (1), 361. doi:10.1186/s12891-024-07472-4

Lehane, F., Malaise, O., Von Frenckell, C., OTTO, B., Docampo Martínez, E., & Ribbens, C. (2024). Hypophosphatasia Presenting as a Chronic Diffuse Pain Syndrome with Extra-Articular Calcifications. Journal of Clinical Medicine, 13 (8), 2263. doi:10.3390/jcm13082263

Peters, C.* , Malaise, O.* , Longton, J., André, B., & Ribbens, C. (December 2023). Vignette thérapeutique de l’étudiant. Prise en charge de la goutte. Revue Médicale de Liège, 78 (12), 733 - 739.
* These authors have contributed equally to this work.

JACQUERIE, P., André, B., de Seny, D., Henket, M., GILTAY, L., Ernst, M., Louis, R., Malaise, M., Ribbens, C., & Guiot, J. (03 November 2023). Reproducibility of pulmonary function tests in patients with systemic sclerosis. Scientific Reports, 13 (1), 18960. doi:10.1038/s41598-023-45881-y

DENIS, A., Frix, A.-N., NGUYEN DANG, D., Malaise, O., DEFOURNY, C., Lovinfosse, P., Corhay, J.-L., GESTER, F., Louis, R., Ribbens, C., & Guiot, J. (November 2023). La pathologie pulmonaire associée à la polyarthrite rhumatoïde. Revue Médicale de Liège, 78 (11), 641-648.

Malaise, O., Bolland, M., & Ribbens, C. (October 2023). Vignette diagnostique de l’étudiant. Prise en charge diagnostique de l’ostéoporose. Revue Médicale de Liège, 78 (10), 586 - 592.

Constant, S., André, B., Malaise, O., GESTER, F., Guiot, J., RIBBENS, C., & Von Frenckell, C. (September 2023). USE OF IL-6 RECEPTOR INHIBITOR FOR THE MANAGEMENT OF CORTICO-RESISTANT CRYPTOGENIC ORGANIZING PNEUMONIA [Poster presentation]. Belgian Congress of Rheumatology, Gand, Belgium.

Guiot, J., Henket, M., Remacle, C., Cambier, M., Struman, I., Winandy, M.-L., Moermans, C., Louis, E., Malaise, M., Ribbens, C., Louis, R., & Njock, M.-S. (15 April 2023). Systematic review of overlapping microRNA patterns in COVID-19 and idiopathic pulmonary fibrosis. Respiratory Research, 24 (1), 112. doi:10.1186/s12931-023-02413-6

Bolland, M., Malaise, O., & Ribbens, C. (April 2023). Une nouveauté dans la prise en charge de l’ostéoporose post-ménopausique à très haut risque fracturaire : le romosozumab (Evenity®), un anticorps monoclonal anti-sclérostine. Revue Médicale de Liège, 78 (4), 239 - 244.

Malaise, O., André, C., Van Durme, C., Seidel, L., Schleich, F., Louis, R., Malaise, M., & Ribbens, C. (20 March 2023). Lung Function Impairment, Associating Hyperinflation with Impaired Diffusion Capacity and Transfer Coefficient, Is a Risk Factor for Hip Osteoporosis in Patients with Chronic Obstructive Pulmonary Disease. Journal of Clinical Medicine, 12 (6), 2383. doi:10.3390/jcm12062383

Docampo Martínez, E., Lehane, F., & Ribbens, C. (2023). Le syndrome d’Ehlers Danlos : une maladie rare fréquemment suspectée. Revue Médicale de Liège, 78 (11), 626 - 633.

MALAISE, M., CHAPELIER, N., DEWAEL, T., LEONORI, L., LEROY, M., Mailleux, E., André, B., Halleux, S., KAISER, M.-J., MALAISE, O., RIBBENS, C., RINKIN, C., VON FRENCKELL, C., & VOLDERS, A. (May 2020). Une révolution thérapeutique en rhumatologie : oui, mais… Revue Médicale de Liège, 75 (5-6), 369-375.

Gendebien, Z., VON FRENCKELL, C., RIBBENS, C., ANDRE, B., THYS, M., GANGOLF, M., SEIDEL, L., Malaise, M., & MALAISE, O. (2020). Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments. Annals of the Rheumatic Diseases. doi:10.1136/annrheumdis-2020-218244

Varkas, G., RIBBENS, C., Louis, E., Van den Bosch, F., Lories, R., Vermeire, S., Elewaut, D., & De Vos, M. (2019). Expert consensus: practical algorithms for management of inflammatory bowel disease patients presenting with back pain or peripheral arthropathies. Alimentary Pharmacology and Therapeutics, 50 (11-12), 1204-1213. doi:10.1111/apt.15519

DE SENY, D., Sharif, M., Fillet, M., COBRAIVILLE, G., Meuwis, M.-A., Marée, R., HAUZEUR, J.-P., Wehenkel, L., Louis, E., Merville, M.-P., Kirwan, J., Ribbens, C., & Malaise, M. (2011). Discovery and biochemical characterisation of four novel biomarkers for osteoarthritis. Annals of the Rheumatic Diseases, 70 (6), 1144-52. doi:10.1136/ard.2010.135541

De Seny, D., Ribbens, C., Cobraiville, G., Meuwis, M.-A., Marée, R., Geurts, P., Wehenkel, L., Louis, E., Merville, M.-P., Fillet, M., & Malaise, M. (2009). Protéomique par SELDI-TOF-MS des maladies inflammatoires articulaires: identification des protéines S100 comme protéines d'intérêt. Revue Médicale de Liège, 64 (Spec No), 29-35.

Vander Cruyssen, B., RIBBENS, C., Boonen, A., Mielants, H., de Vlam, K., Lenaerts, J., Steinfeld, S., Van den Bosch, F., Dewulf, L., & Vastesaeger, N. (August 2007). The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice. Annals of the Rheumatic Diseases, 66 (8), 1072-7. doi:10.1136/ard.2006.064543

De Seny, D.* , Fillet, M.* , Meuwis, M.-A., Geurts, P., Lutteri, L., Ribbens, C., Bours, V., Wehenkel, L., Piette, J., Malaise, M., & Merville, M.-P. (2005). Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. Arthritis and Rheumatism, 52 (12), 3801-12. doi:10.1002/art.21607
* These authors have contributed equally to this work.

Relic, B., Benoit, V., Franchimont, N., Ribbens, C., Kaiser, M.-J., Gillet, P., Merville, M.-P., Bours, V., & Malaise, M. (2004). 15-deoxy-delta12,14-prostaglandin J2 inhibits Bay 11-7085-induced sustained extracellular signal-regulated kinase phosphorylation and apoptosis in human articular chondrocytes and synovial fibroblasts. Journal of Biological Chemistry, 279 (21), 399-403. doi:10.1074/jbc.M314118200

Ribbens, C., Martin y Porras, M., Franchimont, N., Kaiser, M.-J., Jaspar, J. M., Damas, P., Houssiau, F. A., & Malaise, M. (2002). Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment. Annals of the Rheumatic Diseases, 61 (2), 161-166. doi:10.1136/ard.61.2.161

RIBBENS, C., Dayer, J. M., & Chizzolini, C. (February 2000). CD40-CD40 ligand (CD154) engagement is required but may not be sufficient for human T helper 1 cell induction of interleukin-2- or interleukin-15-driven, contact-dependent, interleukin-1beta production by monocytes. Immunology, 99 (2), 279-86. doi:10.1046/j.1365-2567.2000.00948.x

Andre, B., Ribbens, C., Kaye, O., & Malaise, M. (April 1997). Les manifestations osteo-articulaires du sujet âgé. Revue Médicale de Liège, 52 (4), 270-277.

Kaye, O., Ribbens, C., Kahn, M. F., & Malaise, M. (1997). Sarcoidosis: recognition and treatment guidelines. BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, 7 (6), 441-447. doi:10.2165/00063030-199707060-00003

Kaye, O., Ribbens, C., Hauwaert, C., & Malaise, M. (1995). Le méthotrexate en rhumatologie: une révolution thérapeutique. Revue Médicale de Liège, 50 (11), 453-457.